Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial

被引:7
|
作者
Blom, Kerstin [1 ,2 ]
Forsell, Erik [1 ,2 ]
Hellberg, Monica [2 ]
Svanborg, Cecilia [1 ,2 ]
Jernelov, Susanna [1 ,2 ,3 ]
Kaldo, Viktor [1 ,2 ,4 ]
机构
[1] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden
[2] Stockholm Hlth Care Serv, Stockholm, Sweden
[3] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden
[4] Linnaeus Univ, Fac Hlth & Life Sci, Dept Psychol, Vaxjo, Sweden
关键词
Insomnia; Depression; Comorbidity; Psychological treatment; Randomized controlled trial; COGNITIVE-BEHAVIORAL THERAPY; SLEEP RESTRICTION THERAPY; SELF-HELP; DSM-IV; MAJOR DEPRESSION; SOCIAL ANXIETY; FOLLOW-UP; CBT-I; METAANALYSIS; PHARMACOTHERAPY;
D O I
10.1159/000536063
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Insomnia and depression are highly prevalent disorders and commonly occur together. Cognitive behavioral therapy for insomnia, CBT-I, has been shown to be effective in treating insomnia and also comorbid depression. However, it is unclear whether effects of CBT-I on depression are specific or nonspecific. Also, depressive symptoms often remain too high after CBT-I, indicating a need for improved treatments. The objective was to determine whether combining CBT-I with CBT for depression, without increasing treatment length, reduces both insomnia and depression more than CBT for depression with a placebo insomnia intervention. Methods: A 12-week double-blind randomized controlled trial with a 6-month follow-up in a psychiatric setting using therapist-guided internet-delivered treatments was conducted. Patients (N = 126) were diagnosed with insomnia disorder and major depression by physicians. Primary outcome measures were as follows: self-rating scales Insomnia Severity Index (ISI) and Montgomery-angstrom sberg Depression Rating Scale (MADRS-S). Results: The combined treatment showed specific effects on insomnia severity over the control treatment (p = 0.007) but was not more effective in reducing depression severity. Within-group effects (Cohen's d) at post and at 6 months were as follows: ISI 1.40 and 1.42 (combined treatment), 0.95 and 1.00 (control); MADRS-S 0.97 and 1.12 (combined), 0.88 and 0.89 (control). Conclusions: CBT-I shows large specific effects on insomnia severity and is superior to control in this regard. Both treatments had similar effects on depression severity, i.e., combining CBT-I with CBT for depression did not enhance outcomes on depression compared to control. We suggest CBT-I should always be offered to patients with insomnia and depression comorbidity, possibly as the first-hand choice. Combining it with a psychological treatment for depression could be too burdening and may not be beneficial.
引用
收藏
页码:100 / 113
页数:14
相关论文
共 50 条
  • [41] A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression
    Romijn, Amy R.
    Rucklidge, Julia J.
    Kuijer, Roeline G.
    Frampton, Chris
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 (08) : 810 - 821
  • [42] Efficacy and safety of celecoxib for treatment of mild to moderate postpartum depression: a randomized, double-blind, placebo-controlled trial
    Esalatmanesh, Sophia
    Kashani, Ladan
    Khooshideh, Maryam
    Moghaddam, Hossein Sanjari
    Ansari, Sahar
    Akhondzadeh, Shahin
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 309 (04) : 1429 - 1439
  • [43] A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence
    Brown, E. Sherwood
    Gabrielson, Barry
    JOURNAL OF AFFECTIVE DISORDERS, 2012, 143 (1-3) : 257 - 260
  • [44] Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double- Blind, Randomized, Placebo-Controlled Trial
    Zhou, Jiaojiao
    Chen, Xu
    Xiao, Le
    Zhou, Jingjing
    Feng, Lei
    Wang, Gang
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [45] The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial
    Abbasi, Behnood
    Kimiagar, Masud
    Sadeghniiat, Khosro
    Shirazi, Minoo M.
    Hedayati, Mehdi
    Rashidkhani, Bahram
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (12): : 1161 - 1169
  • [46] Trimethoprim as Adjuvant Treatment in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Shibre, Teshome
    Alem, Atalay
    Abdulahi, Abdulreshid
    Araya, Mesfin
    Beyero, Teferra
    Medhin, Girmay
    Deyassa, Negusse
    Negash, Alemayehu
    Nigatu, Alemayehu
    Kebede, Derege
    Fekadu, Abebaw
    SCHIZOPHRENIA BULLETIN, 2010, 36 (04) : 846 - 851
  • [47] Lansoprazole in Globus Pharyngeus: Double-Blind, Randomized, Placebo-Controlled Trial
    Dumper, Jaymi
    Mechor, Brad
    Chau, Jason
    Allegretto, Michael
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2008, 37 (05): : 657 - 663
  • [48] Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer-a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
    Jakobsen, Gunnhild
    Sjue, Karin
    Paulsen, Ornulf
    Kaasa, Stein
    Hjermstad, Marianne Jensen
    Klepstad, Pal
    SUPPORTIVE CARE IN CANCER, 2023, 31 (01)
  • [49] Individualized Homeopathic Medicines as Adjunctive Treatment of Pediatric Epilepsy: A Double-Blind, Randomized, Placebo-Controlled Trial
    Gupta, Bharti
    Misra, Pankhuri
    Karuppusamy, Avaranjika
    Balamurugan, Dharshna
    Parewa, Maneet
    Tomar, Maneela
    Rai, Shruti
    Vashishth, Himani
    Sadhukhan, Satarupa
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    HOMEOPATHY, 2023, 112 (03) : 170 - 183
  • [50] A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women
    Rahman, Shadab A.
    Nathan, Margo D.
    Wiley, Aleta
    Crawford, Sybil
    Cohn, Aviva Y.
    Harder, Jessica A.
    Grant, Leilah K.
    Erickson, Athena
    Srivastava, Akanksha
    McCormick, Kathleen
    Bertisch, Suzanne M.
    Winkelman, John W.
    Joffe, Hadine
    SLEEP, 2022, 45 (03)